Business Context and Reporting Period
This Form 8-K filing by Anthem, Inc. (now Elevance Health, Inc.) was submitted on January 30, 2019. The report primarily serves to incorporate by reference a press release detailing the Company's financial results for the fourth quarter ended December 31, 2018.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the referenced Press Release (Exhibit 99.1), which is not included in the provided text.
Material Changes and Strategic Actions
- Termination of Pharmacy Benefits Agreement: The Company announced the termination of its pharmacy benefits management (PBM) services agreement with Express Scripts, Inc., effective March 1, 2019.
- Transition of Services: The Company is transitioning PBM services to CaremarkPCS Health, L.L.C., a subsidiary of CVS Health Corporation.
Guidance, Risks, and Contingencies
The filing includes extensive forward-looking statements and risk disclosures. Key areas of uncertainty and risk identified include:
- Regulatory Environment: Ongoing changes to the Affordable Care Act (ACA) and potential legal challenges.
- Operational Transition: Risks associated with the transition from Express Scripts to CaremarkPCS, including potential financial penalties, inability to meet customer demands, and sanctions from governmental entities like CMS.
- Legal Litigation: Ongoing litigation with Cigna Corporation regarding a failed merger agreement, which could result in substantial costs, termination fees, and reputational damage.
- Market and Financial Risks: Healthcare cost trends, competitive pressures, cybersecurity threats, and the impact of substantial outstanding indebtedness.
Investor Verification Checklist
- Review the full text of the January 30, 2019 Press Release (Exhibit 99.1) for specific Q4 2018 financial results.
- Monitor the status of the PBM transition to CaremarkPCS Health and any associated regulatory approvals or penalties.
- Track developments in the litigation between Anthem and Cigna Corporation regarding the merger termination.
- Assess the impact of ACA regulatory changes on the Company's product mix and premium rates.